Cart

Uncategorized

Cannabidiol (CBD) has been the focus of many medical cannabis studies, and continues to prove itself as a powerful anti-inflammatory drug. What makes CBD even more desirable for some patients is that it does not cause the psychoactive effects associated with tetrahydrocannabinol (THC).   

Cannabidiol (CBD) is an exciting focus of medical research, popular media, and legislation related to cannabis. Its presence is becoming ubiquitous on the shelves of health food stores and search engine results for numerous medical conditions, but don’t believe everything you hear. While CBD is an incredibly safe and therapeutic component of cannabis, there are many myths and misconceptions associated with it. Let’s take a look at a few.   

One of the effects of chronic cannabinoid use could be a more subdued response when faced with stressful situations, according to a new study published Psychopharmacology. Scientists from Washington State University found that when placed in a simulated stressful situation, those who regularly consume cannabinoids produce less cortisol, the body’s main stress hormone. 

When it comes to treating mental illnesses – especially depression – the options are unfortunately extremely limited. Most of the time pharmaceutical drugs can take weeks, if not months, before the patient notices a difference and oftentimes antidepressant medications are extremely addictive with a long list of potential side effects if you quit taking them suddenly. The worst part is that antidepressants only work for some people – at least 1 in 3 people with depression are unable to find relief through current antidepressant drugs.   

Now that recreational marijuana use is legal in eight states, more people are finding themselves wondering what the law says about traveling with cannabis. Complicating matters, the TSA has issued somewhat vague guidelines about what is permissible and what isn’t. And most of the confusion has to do with the status, not of dried flower, but of oils and extracts. Take CBD oil, for example, some types of which are legal everywhere. Can you bring CBD oil on planes? For the most part, yes. And here’s why you might want to.   

The most prominent form of synovial joint disease, osteoarthritis (OA), is characterized by joint degeneration, pain, and in some patients, articular neuropathy.  Chronic pain associated with OA is a major concern for which there are few viable treatments. The first line therapy used to treat OA pain is non-steroidal anti-inflammatory drugs (NSAIDs); however, withlong-term use their efficacy declines and they can lead to major adverse gastrointestinal and cardiovascular events.  Historically, OA has been classified as a non-inflammatory arthritis; however, there is now overwhelming evidence that synovitis can occur in response to pro inflammatory mediators being released into the joint. It is believed that this low-level inflammation contributes to degenerative changes that affect the entire joint leading to the development of peripheral sensitization and nociceptive pain . In addition to structural defects, there is growing evidence to suggest that approximately 30% of OA patients suffer from neuropathic pain. Thus, a therapeutic which can block inflammation, neuropathy, and pain is sorely needed The endocannabinoid system (ECS) plays an important physiological role in the regulation of tissue inflammation and pain. A functional ECS has been demonstrated in the joints of animals and humans, which acts tonically to maintain joint homeostasis.